OR1L3

mutation — cross-omics
Cross-omicsMUTATION → RNACell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, OR1L3 mutation is significantly associated with the RNA expression of many other genes, with 10 significant associations in total. BLOOD_Leukemia shows the largest number of these associations.

The most reproducible OR1L3-associated genes across cancer lineages are IDI2, ASB17, and CST9. Each is linked with OR1L3 in more than 1 cancer types. Because this analysis shows association rather than direction, both OR1L3-to-partner and partner-to-OR1L3 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, IDI2 grouped by OR1L3-low versus OR1L3-high in OVARY.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (OR1L3→partner) and Y-score (partner→OR1L3) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
OVARYIDI2 →+0.029+4.029<.001.00931
OVARYASB17 →+0.017+4.807<.001.00331
OVARYCST9 →+0.005+4.807<.001.00331
BLOOD_LeukemiaLCE1C →+0.432+4.922.002.00931
BLOOD_LeukemiaSLC5A8 →+0.182+5.201<.001.00631
BLOOD_LeukemiaOR10A6 →+0.044+5.201<.001.00631
Each partner links to its Q-omics profile. Showing the 6 strongest of 10 associations by consensus.

IDI2 by OR1L3 expression — OVARY

Box plot of IDI2 in OR1L3-low vs OR1L3-high samples in OVARY.

Explore this box plot interactively →

Exploration